New Search

If you are not happy with the results below please do another search

1 search result for:

1

Carina Biotech to create cancer-busting CAR-T cells using Bionomics antibody

In an exclusive agreement with Bionomics Limited, Australia’s Carina Biotech will create Chimeric Antigen Receptor T cells (CAR-T cells) and other adoptive cell therapies to the leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) using the first-in-class humanised antibody BNC101 developed by Bionomics.